Recurrent Stroke in a Young Patient with Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Quo Vadis?

So far, there has been no generally accepted diagnostic and therapeutic algorithm for patients with embolic stroke of undetermined source (ESUS). As recent clinical trials on secondary stroke prevention in ESUS did not support the use of oral anticoagulation and the concept of ESUS comprises heterog...

Descripción completa

Detalles Bibliográficos
Autores principales: Feil, Katharina, Heinrich, Johanna, von Falkenhausen, Aenne S., Becker, Regina, Küpper, Clemens, Müller, Katharina, Thunstedt, Dennis C., Sinner, Moritz F., Kääb, Stefan, Kellert, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Single Case - General Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036551/
https://www.ncbi.nlm.nih.gov/pubmed/32110227
http://dx.doi.org/10.1159/000505180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036551/
https://www.ncbi.nlm.nih.gov/pubmed/32110227
http://dx.doi.org/10.1159/000505180

Ejemplares similares